Rapid Micro Biosystems, Inc.
RPID
$1.88
-$0.11-5.53%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.00M | 11.28M | 7.84M | 7.26M | 7.21M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.00M | 11.28M | 7.84M | 7.26M | 7.21M |
| Cost of Revenue | 7.63M | 11.61M | 7.14M | 6.99M | 6.80M |
| Gross Profit | 371.00K | -328.00K | 696.00K | 275.00K | 404.00K |
| SG&A Expenses | 10.86M | 8.66M | 8.54M | 9.19M | 8.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.85M | 23.49M | 19.21M | 19.41M | 18.87M |
| Operating Income | -13.85M | -12.21M | -11.37M | -12.15M | -11.66M |
| Income Before Tax | -14.27M | -12.48M | -11.50M | -11.85M | -11.26M |
| Income Tax Expenses | 8.00K | 14.00K | 8.00K | 11.00K | 7.00K |
| Earnings from Continuing Operations | -14.28M | -12.50M | -11.51M | -11.86M | -11.26M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -14.28M | -12.50M | -11.51M | -11.86M | -11.26M |
| EBIT | -13.85M | -12.21M | -11.37M | -12.15M | -11.66M |
| EBITDA | -13.15M | -11.62M | -10.67M | -11.44M | -10.91M |
| EPS Basic | -0.31 | -0.28 | -0.26 | -0.27 | -0.26 |
| Normalized Basic EPS | -0.20 | -0.17 | -0.16 | -0.17 | -0.16 |
| EPS Diluted | -0.31 | -0.28 | -0.26 | -0.27 | -0.26 |
| Normalized Diluted EPS | -0.20 | -0.17 | -0.16 | -0.17 | -0.16 |
| Average Basic Shares Outstanding | 45.43M | 44.62M | 44.96M | 44.65M | 43.99M |
| Average Diluted Shares Outstanding | 45.43M | 44.62M | 44.96M | 44.65M | 43.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |